May is Preeclampsia Awareness Month

Preeclampsia: Move Research Forward

Last Updated on March 20, 2023


May is Preeclampsia Awareness Month, a month-long communication campaign to raise awareness of life-threatening hypertensive disorder of pregnancy.

Our 2023 theme is "Move Preeclampsia Research Forward."

Researchers and clinicians still do not fully understand why preeclampsia and other hypertensive disorders occur in 5-8% of all pregnancies. Currently, the only treatment for preeclampsia starts with delivery of the baby and the placenta, no matter how far into pregnancy a mother may be, hoping that mom's health will improve.

We can do better for pregnant and postpartum patients and their infants, but it takes us all: patients participating in research. Researchers receiving funding to investigate preeclampsia. Clinicians implementing what research shows saves lives. Policymakers prioritizing maternal health research funding in general and preeclampsia research in specific.

Join us in raising your voice for preeclampsia awareness!

Social Media Hashtags

#PreeclampsiaAwarenessMonth #Preeclampsia

#MoveResearchForward #MyPreeclampsiaStory

 

Follow Us on Social Media

facebook-logo.jpg (49 KB)   Instagram_sq.png (166 KB)  twitter-logo.jpg (75 KB)  Linkedin-logo-icon-png.png (3 KB)  YouTube_Square.png (21 KB)

 

World Preeclampsia Day Recap!

May 22 is World Preeclampsia Day. In 2022, we asked global patient leaders to share the preeclampsia journey of women in their countries. 

 
 
 

Key Statistics About Preeclampsia

  • Hypertensive disorders of pregnancy (HDPs) complicate 5-10% of all pregnancies worldwide.They include:
    • preeclampsia (with or without severe features),
    • eclampsia (seizures),
    • HELLP syndrome (hemolysis, elevated liver enzymes, low platelets),
    • gestational hypertension.[i]
  • Preeclampsia is most often characterized by a rapid rise in blood pressure that can lead to:
    • seizure,
    • stroke,
    • multiple organ failure,
    • death of the mother and/or baby.
  • HDPs are a leading cause of maternal and infant death worldwide[ii], with the majority of these deaths happening in low- and middle-income countries (LMICs).
  • Approximately 76,000 women and 500,000 babies die each year worldwide.[iii] 
  • The United States currently ranks 47th worldwide for maternal mortality, and is the only industrialized nation with a rising maternal mortality rate.[iv]
  • HDPs, including preeclampsia, are a leading cause of maternal and infant illness and death here in the United States.[v]
  • Black women experience severe maternal morbidity events at a rate 2.1 times greater than white women.[vi]

Key Statistics on Ending Preeclampsia's Impact

  • Easy-to-understand preeclampsia signs and symptoms education tools can improve patient understanding of what to report to their healthcare providers.[xiv]
  • Aspirin during the first trimester, early hypertension control, nutrition, and exercise may all help to decrease rates of preeclampsia.[vii],[viii],[ix],[x]
  • Standardizing and deploying care guideline "bundles" on the leading causes of maternal mortality, including hypertensive disorders of pregnancy, have been shown to decrease maternal illness and death.[xi], [xv]
  • Perinatal quality collaboratives can help hospitals to implement care practices that reduce early delivery and reduce severe pregnancy complications.[xii]
  • Countinuous support through the prenatal period, labor and delivery, and the postpartum period by midwives, doulas, and other trained childbirth attendants can improve pregnancy outcomes for all moms, but especially those in the BIPOC community.[xiii]

2022 Social Media Messages

Spreading awareness can be as simple as sending a message on social media - and be sure to tag us in your posts!

  1. May is National Preeclampsia Awareness Month - that's why we partner with the Preeclampsia Foundation to kick off a month of ensuring that EVERY mother in any pregnancy knows the signs and symptoms of preeclampsia. Learn more at www.preeclampsia.org/AwarenessMonth and join the campaign by sharing this graphic! #PreeclampsiaAwarenessMonth
  2. Know the symptoms of #preeclampsia: severe headache, swelling in the hands and face, visual issues, nausea and vomiting, stomach or abdomen pain, sudden weight gain, and/or shortness of breath. Preeclampsia can occur in any pregnancy, so ALL moms need to know. #PreeclampsiaAwarenessMonth
  3. Postpartum preeclampsia can happen up to six weeks postpartum. It's important that women pay attention to specific postpartum symptoms, including severe headache, vision changes, swelling of the hands and face, and especially difficulty breathing. Help share this video to educate others on what they need to know: http://www.stillatrisk.org #PreeclampsiaAwarenessMonth
  4. Preeclampsia rates are on the rise in the US and are a leading cause of maternal and infant illness and death. All women need to know the risk factors for developing high blood pressure during pregnancy - and that you can also have no risk factors, but still may develop it. Share this link: https://preeclampsia.org/aspirin #PreeclampsiaAwarenessMonth

Use our "31 Days of Tweets" sheet to share out a fact-a-day about preeclampsia and Preeclampsia Awareness Month.

 

2022 Social Media Graphics

Spreading awareness can be as simple as sharing a graphic on social media.

PreAM-graphic.png (1.08 MB)  May 2 2022.png (807 KB)  May 4 2022.png (668 KB)

May 15 2022.png (708 KB)  76,000-moms-graphic.png (864 KB)  preventable-graphic.png (965 KB)

 

Educational Videos

We have a wide range of educational videos available to assist both community members and medical professionals alike.

7 Symptoms Every Pregnant Woman Should Know (tambien disponible en Español)

Aspirin may prevent or delay the onset of preeclampsia (tambien disponible en Español)

Postpartum Preeclampsia: Still At Risk (tambien disponible en Español)

[i] Ye, C., Ruan, Y., Zou, L., Li, G., Li, C., Chen, Y., … Zhang, W. (2014). The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP) in China: Prevalence, Risk Factors, Complications, Pregnancy and Perinatal Outcomes. PLoS ONE, 9(6), e100180. http://doi.org/10.1371/journal.pone.0100180
[ii] Khan KS, Wojdyla D, Say L, Gulmezoglu M, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet 2006; 367:1066-74.
[iii] Salam R. A., Das, J. K., Ali, A., Bhuamik, S., and Lassi, Z.S. (2015). Diagnosis and management of preeclampsia in community settings in low and middle-income countries. Journal of Family Med Prim Care, 4(4), 501–506. http://doi.org/10.4103/2249-4863.174265
[iv] MacDorman, M., Declercq, E., Cabral, H., Morton, C., “Is the United States Maternal Mortality Rate Increasing? Disentangling trends from measurement issues: Short title: U.S. Maternal Mortality Trends.” Journal of Obstetrics and Gynecology. September, 2016.
[v] Center for Disease Control Pregnancy Mortality Surveillance System: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm
[vi] Racial Disparities Persist in Maternal Morbidity, Mortality and Infant Health: https://www.ajmc.com/view/racial-disparities-persist-in-maternal-morbidity-mortality-and-infant-health
[vii] US Preventative Services Task Force, Low Dose Aspirin Use for the Prevention of Morbidity and Mortality from Preeclampsia: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
[viii] Tita, A, et al, "Treatment for Mild Chronic Hypertension during Pregnancy" April 2022: https://www.nejm.org/doi/full/10.1056/NEJMoa2201295
[ix] Minhas, A; Hong, X; et al. "Mediterranean‐Style Diet and Risk of Preeclampsia by Race in the Boston Birth Cohort" Journal of the American Heart Association, April 2022: https://doi.org/10.1161/JAHA.121.022589
[x] Danielli M, Gillies C, Thomas RC, Melford SE, Baker PN, Yates T, Khunti K, Tan BK. Effects of Supervised Exercise on the Development of Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis. J Clin Med. 2022 Feb 1;11(3):793. doi: 10.3390/jcm11030793. PMID: 35160245; PMCID: PMC8836524.
[xi] The Role of Patient Safety Bundles, Alliance for Innovation on Maternal Health: https://safehealthcareforeverywoman.org/aim/patient-safety-bundles/
[xii] Center for Disease Control, Perinatal Quality Collaboratives: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pqc.htm
[xiii] Hodnett ED, Gates S, Hofmeyr GJ, Sakala C. Continuous support for women during childbirth. Cochrane Database of Systematic Reviews 2013, Issue 7. Art. No.: CD003766. DOI: 10.1002/14651858.CD003766.pub5.
[xiv] You WB, Wolf MS, Bailey SC, Grobman WA. Improving patient understanding of preeclampsia: a randomized controlled trial. Am J Obstet Gynecol. 2012 May;206(5):431.e1-5. doi: 10.1016/j.ajog.2012.03.006. Epub 2012 Mar 13. PMID: 22542120.
[xv] Arora KS, Shields LE, Grobman WA, D'Alton ME, Lappen JR, Mercer BM. Triggers, bundles, protocols, and checklists--what every maternal care provider needs to know. Am J Obstet Gynecol. 2016 Apr;214(4):444-451. doi: 10.1016/j.ajog.2015.10.011. Epub 2015 Oct 23. PMID: 26478105.